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Abstract
Background:  We previously demonstrated that overexpression of Golgi-localized, γ-ear
containing, Arf-binding (GGA) proteins inhibits retrovirus assembly and release by disrupting the
function of endogenous ADP ribosylation factors (Arfs). GGA overexpression led to the formation
of large, swollen vacuolar compartments, which in the case of GGA1 sequestered HIV-1 Gag.
Results: In the current study, we extend our previous findings to characterize in depth the GGA-
induced compartments and the determinants for retroviral Gag sequestration in these structures.
We find that GGA-induced structures are derived from the Golgi and contain aggresome markers.
GGA overexpression leads to defects in trafficking of transferrin receptor and recycling of cation-
dependent mannose 6-phosphate receptor. Additionally, we find that compartments induced by
GGA overexpression sequester Tsg101, poly-ubiquitin, and, in the case of GGA3, Hrs.
Interestingly, brefeldin A treatment, which leads to the dissociation of endogenous GGAs from
membranes, does not dissociate the GGA-induced compartments. GGA mutants that are defective
in Arf binding and hence association with membranes also induce the formation of GGA-induced
structures. Overexpression of ubiquitin reverses the formation of GGA-induced structures and
partially rescues HIV-1 particle production. We found that in addition to HIV-1 Gag, equine
infectious anemia virus Gag is also sequestered in GGA1-induced structures. The determinants in
Gag responsible for sequestration map to the matrix domain, and recruitment to these structures
is dependent on Gag membrane binding.
Conclusion: These data provide insights into the composition of structures induced by GGA
overexpression and their ability to disrupt endosomal sorting and retroviral particle production.
Background
The Gag polyprotein precursors are the key structural ele-
ments driving retroviral particle production. The N-termi-
nal matrix (MA) domain of the Gag precursor is important
for plasma membrane (PM) targeting and membrane
binding. Following Gag targeting, the process of assembly
proceeds via Gag multimerization mediated primarily by
sequences within the capsid (CA) and nucleocapsid (NC)
domains. Finally, the "late" domains in Gag mediate the
terminal step in particle production - the pinching off of
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the virion from the infected cell membrane [1-5]. Con-
comitant with virus release the particle undergoes matura-
tion, a structural reorganization of the virion that results
from a highly concerted catalytic cascade mediated by the
viral protease (PR) [5,6].
While the Gag precursor proteins are the sole viral deter-
minants required for the production of immature virus-
like particles (VLPs), a number of host factors have been
implicated in various steps of the virus assembly and
release pathway. Retroviral late domains are known to
interact with components of the endosomal sorting
machinery. For example, the HIV-1 Gag precursor protein,
Pr55Gag, contains in its p6 domain a Pro-Thr/Ser-Ala-Pro
[P(T/S)AP] motif that binds Tsg101, a component of the
endosomal sorting complex required for transport-I
(ESCRT-I) [7-10], and a Tyr-Pro-Xn-Leu (YPXnL, where X is
any amino acid and n = 1-3 residues) motif that interacts
with the ESCRT-associated factor Alix [11-13]. The physi-
ological role of the ESCRT machinery is to promote the
biogenesis of vesicles that bud into the lumen of late
endosomes to form multivesicular bodies (MVBs) [14].
The recruitment of Tsg101 from the cytoplasm to endo-
somal membranes occurs via interaction between Tsg101
and hepatocyte growth factor-regulated tyrosine kinase
substrate (Hrs) [15-17]. The delivery of cargo proteins to
MVBs usually requires the recognition by ESCRT machin-
ery of monoubiquitin moieties attached to the cytoplas-
mic domains of the cargo. In yeast, disruption of any of
the components of the ESCRT complexes and associated
factors (known as class E VPS proteins) results in failure of
proper sorting of ubiquitinated proteins and induction of
an aberrant class E compartment [18-20]. Retroviral Gag
proteins are also ubiquitinated [21-23], and while ubiqui-
tination of Gag does not appear to play an essential role
in virus budding [24], in the absence of a functional late
domain ubiquitin can serve to promote virus release [25].
In addition to serving a well-established role in retrovirus
budding, host cell factors have also been reported to func-
tion in promoting Gag trafficking to the PM. We previ-
ously reported that the phospholipid
phosphatidylinositol-(4,5)-bisphosphate [PI(4,5)P2] is a
key cellular cofactor for HIV-1 Gag targeting to the PM
[26] via a direct MA-PI(4,5)P2 interaction [27,28]. The
clathrin adaptor protein complexes 1, 2, and 3 (AP-1, 2,
and 3) [29-31], suppressor of cytokine signaling 1
(SOCS1) [32], the kinesin KIF4 [33,34], staufen 1 [35],
and plenty of SH3s (POSH) [36] have all been implicated
in Gag targeting to the PM. We demonstrated previously
that overexpression of the Golgi-localized, γ-ear contain-
ing, Arf-binding (GGA) proteins inhibits the production
of HIV-1 and equine infectious anemia virus (EIAV) parti-
cles by impairing the association of Gag with membrane
[37]. The impairment in Gag-membrane binding induced
by GGA overexpression was linked to functional disrup-
tion of the endogenous ADP ribosylation factors (Arfs)
[37].
The GGA proteins are a family of monomeric clathrin
adaptors primarily localized at the trans-Golgi network
(TGN), although also reported to be present in late endo-
somes [38-41]. Three GGA proteins (GGA1, 2, and 3) are
expressed in mammals and two in yeast and there is
ample evidence demonstrating that these proteins help
package cellular cargo into clathrin-coated vesicles [39].
GGAs are comprised of four distinct domains: 1) an N-ter-
minal Vps27, Hrs, and STAM homology (VHS) domain
that binds cargo proteins and cargo protein receptors [e.g.,
cation-dependent mannose 6-phosphate receptors (CD-
MPR)] bearing Asp-X-X-Leu-Leu [DXXLL] motifs; 2) a
GGA and Tom (GAT) domain that binds Arfs, ubiquitin,
and Tsg101; 3) a hinge region that recruits clathrin; and 4)
a C-terminal γ-adaptin ear homology (GAE) domain that
binds several proteins including rabaptin 5, epsinR, and γ-
synergin. The GAT domain is responsible for recruitment
of GGA proteins to membrane via interaction with GTP-
bound Arf [39].
Previously, we reported that GGA overexpression induces
the formation of large swollen vacuolar compartments
that sequester Arf proteins. The compartments induced by
GGA1, but not those induced by GGA2 or GGA3, also
sequester HIV-1 Gag [37]. We and others have also dem-
onstrated in previous studies that overexpression of dom-
inant-negative or full-length components of the ESCRT
complexes and associated machinery gives rise to the for-
mation of aberrant compartments that disrupt retroviral
particle production. For example, overexpression of full-
length Tsg101 (TSG-F) induces a class E-type compart-
ment that potently disrupts HIV-1 budding but has mini-
mal effect on EIAV release [42,43]. Overexpression of the
C-terminal portion of Tsg101 (TSG-3') generates aggre-
some-like structures and severely inhibits the release of
HIV-1, murine leukemia virus (MLV), and Rous sarcoma
virus (RSV) but does not disrupt EIAV release [42-44]. A
dominant-negative, ATPase-deficient mutant of Vps4 is
highly disruptive to the release of a number of retroviruses
including HIV-1, EIAV, RSV, and feline immunodefi-
ciency virus (FIV) [8,11,25,43,45-47]. It is noteworthy
that each of the compartments described above is mor-
phologically distinct and imposes selective defects on spe-
cific steps in the retroviral assembly and release pathway.
For example, GGA overexpression leads to a defect in Gag
trafficking to the PM, whereas TSG-F, TSG-3', and domi-
nant-negative Vps4 overexpression inhibits particle bud-
ding and release.
In the current study, we characterized the compartments
induced by GGA overexpression with regard to their com-BMC Cell Biology 2009, 10:72 http://www.biomedcentral.com/1471-2121/10/72
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position as well as their impact on retrovirus assembly
and cellular endosomal sorting pathways. Our data dem-
onstrate that GGA overexpression causes various sorting
defects as measured by recycling of CD-MPR, internaliza-
tion of transferrin receptor (TfR), and the subcellular
localization of proteins like Tsg101, ubiquitin, and Hrs.
The determinants for HIV-1 Gag sequestration in GGA1-
induced compartments were mapped to the MA domain.
These data provide novel insights into the defects in cellu-
lar sorting and retrovirus assembly induced by GGA over-
expression.
Results
GGA overexpression induces the generation of enlarged 
vacuolar compartments that bear Golgi markers
Previously we showed that GGA overexpression leads to
the accumulation of large, swollen vacuolar structures and
severely inhibits retrovirus particle production [37]. In the
current study, we sought to characterize in detail the phe-
notype and composition of these GGA-induced struc-
tures. As reported previously [48,49], endogenous GGAs
predominantly localize to a perinuclear region, with some
small puncta also evident at the PM, particularly for GGA3
(Figure 1A, endogenous). All three endogenous GGAs
colocalized with Golgi markers (data not shown). In con-
trast, HeLa cells overexpressing exogenous GGAs showed
the accumulation of large, vacuolar compartments (Figure
1A, exogenous). Similar structures were also evident upon
overexpression of GFP-tagged GGAs but these tended to
be smaller in size (data not shown). These GGA-induced
compartments were seen in approximately half of the
transfected cells (Figure 1A), with those expressing lower
levels of GGA proteins showing a localization pattern sim-
ilar to that of the endogenous GGAs (data not shown). In
parallel, we compared the localization of other cellular
proteins which, when overexpressed, also disrupt retrovi-
ral particle production and induce the formation of
abnormal intracellular structures [19,42,44]. As reported
previously, overexpression of full-length Tsg101 (TSG-F)
[42] or a GFP-fused, dominant-negative E228Q Vps4
mutant (Vps4EQ) [19,50] induced the formation of swol-
len endosomal structures known as class E compartments
(Figure 1A). In contrast, overexpression of the C-terminal
portion of Tsg101 (TSG-3') led to the generation of larger,
aggresome-like structures (Figure 1A) [42,44]. To deter-
mine whether overexpressed GGA proteins colocalized
with each other, we cotransfected cells with vectors
expressing the following combinations of tagged GGA
proteins: GFP-GGA1 + Myc-GGA2, GFP-GGA1 + Myc-
GGA3, and Myc-GGA2 + GFP-GGA3. Microscopic analy-
sis indicated a high degree of colocalization (> 70%) of
these combinations of GGA proteins (data not shown).
We next sought to define the composition and subcellular
origins of the GGA-induced structures. GGA-overexpress-
ing cells were stained with antibodies specific for the
endoplasmic reticulum (ER)-resident proteins calnexin
and calreticulin, the trans-Golgi network (TGN) marker
TGN46, the Golgi matrix marker GM130, the early endo-
some marker early endosomal antigen 1 (EEA1), and the
late endosome marker CD63. We observed that the GGA-
induced structures did not contain ER or late endosome
markers (data not shown) but did display a high degree of
colocalization with TGN46 (Pearson coefficient of corre-
lation R ~ 0.7-0.8) (Figure 1B). Interestingly, only the
GGA3-induced structures stained for GM130 (R ~ 0.8), a
detergent-insoluble component of the Golgi matrix
peripherally associated with the cis compartment (Figure
1B) [51]. These results suggest that GGA overexpression
induces the formation of aberrant compartments derived
from the Golgi but the specific composition of compart-
ments induced by overexpression of GGA1, GGA2, or
GGA3 is not identical.
Brefeldin A dissociates endogenous GGAs from membranes 
but does not lead to a disintegration of GGA-induced 
compartments
Treatment of cells with the fungal toxin brefeldin A (BFA)
leads to the dissociation of Arf-dependent coats, including
the GGA proteins, from membranes [48,52,53]. It was
therefore of interest to determine whether BFA treatment
dissociates GGA-induced structures. Untransfected HeLa
or GGA-overexpressing cells were treated with BFA at 4 μg/
ml for 1 h, fixed and analyzed by fluorescence micros-
copy. BFA treatment led to the apparent dissociation of
endogenous GGAs from membranes, as indicated by a
shift in GGA localization from small puncta to a hazy, dif-
fuse pattern (Figure 2, endogenous). In contrast, BFA
treatment had no effect on the morphology of GGA-
induced structures, and the size and number of swollen
compartments remained unchanged (Figure 2, exoge-
nous). Similar results were seen when cells were treated
with higher BFA concentrations or for longer periods of
time (data not shown). Because the interaction of GGAs
with Arf proteins is important for GGA-membrane bind-
ing, [39,54], as a control we examined the phenotype of
N194A GGA mutants defective in Arf binding. Interest-
ingly, the GGA-N194A mutants also showed massive
accumulation of enlarged, swollen, vacuolar compart-
ments (Figure 2, NA panels). Notably, in cells expressing
low levels of GGA-N194A protein, a diffuse staining pat-
tern was observed (data not shown), consistent with a pre-
vious report [54]. These findings demonstrate that while
endogenous GGA proteins dissociate from membranes
upon BFA treatment, the morphology of GGA-induced
compartments is not altered by BFA treatment. While it is
possible that the BFA insensitivity of the GGA-induced
compartments is due to a high level of exogenous GGA
expression, the BFA data combined with the observation
that Arf-binding-deficient GGA mutants still induce theseBMC Cell Biology 2009, 10:72 http://www.biomedcentral.com/1471-2121/10/72
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compartments suggest that the association of exogenously
expressed GGAs with membrane is not required for the
formation and maintenance of GGA-induced structures.
GGA-induced compartments are positive for the 
aggresome marker GFP-250
We next characterized the GGA-induced compartments by
determining whether they are aggresome-like structures.
Aggresomes are formed in response to protein misfolding
or high protein concentrations in the cytoplasm [55].
Other factors such as a change in pH, temperature, ionic
strength, or inhibition of a specific degradative pathway
can also lead to protein aggregation [56]. GFP-250 is a
protein previously characterized to form aggresome-like
structures; it is composed of GFP fused to a 250-amino
acid fragment of the cytosolic protein and membrane
GGA overexpression leads to accumulation of swollen vacuolar structures that stain positive for Golgi markers Figure 1
GGA overexpression leads to accumulation of swollen vacuolar structures that stain positive for Golgi mark-
ers. (A) HeLa cells were left untransfected or were transfected with vectors expressing Myc-tagged GGA1, GGA2 or GGA3, 
HA-tagged TSG-F or TSG-3', or GFP-Vps4EQ. For detection of endogenous GGA proteins (left panels), cells were stained 
using antibodies specific for GGA1, GGA2 or GGA3. For exogenous GGA or Tsg101 protein detection, cells were stained 
using anti-Myc or anti-HA antibodies, respectively. Cells were analyzed using the DeltaVision RT microscope. Images shown 
were obtained from one of 7-8 independent experiments. (B) HeLa cells were transfected with the GGA expression vectors, 
fixed 24 h posttransfection, and stained with antibodies recognizing TGN46 or GM130. Images were acquired using a DeltaVi-
sion RT microscope and colocalization was determined using the SoftWoRx colocalization module. Numbers represent aver-
age colocalization (R values) ± SD from 10-15 cells. Size bar represents 15 μm.
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transport anchor, p115 [57]. HeLa cells cotransfected with
vectors expressing GFP-250 and Myc-tagged GGA proteins
were stained and analyzed by microscopy (Figure 3A).
GGA-overexpressing compartments colocalized signifi-
cantly with GFP-250. As a positive control, we compared
the GGA-induced structures with those formed upon TSG-
3' expression, as these have been reported to be positive
for GFP-250 [44]. Furthermore, EM analysis of GGA- or
TSG-3'-overexpressing cells showed an abundance of
irregular, electron-dense accumulations of varying densi-
ties, shapes and sizes (Figure 3B), which are typical of
aggresome-like structures.
GGA overexpression sequesters cell sorting machinery
As shown above, GGA overexpression leads to the accu-
mulation of large swollen compartments. We hence inves-
tigated the physiological consequences of GGA
overexpression by monitoring epidermal growth factor
(EGF) receptor internalization, TfR endocytosis, and CD-
MPR recycling. GGA-overexpressing cells were treated
with Texas Red-tagged EGF or fluorescently tagged trans-
ferrin (Tf-594) conjugates in serum free medium, fol-
lowed by fluorescence microscopy. GGA overexpression
did not significantly alter EGF receptor internalization
(data not shown). However, GGA overexpression led to
abnormal uptake of transferrin conjugates from the PM.
As shown in Figure 4A, in control cells, Tf-594 is rapidly
internalized from the PM and can be readily detected in
the perinuclear region within 15 minutes. In contrast,
cells overexpressing the GGA proteins showed markedly
diminished staining with Tf-594 (Figure 4A) at time zero
due to sequestration of TfR in GGA-induced compart-
ments as detected by staining of GGA-overexpressing cells
with anti-TfR antibody (Figure 4B). GGA overexpression
also led to the steady-state accumulation of CD-MPR
within GGA-induced structures and its depletion from the
periphery (Figure 4C). These data demonstrate that over-
expression of GGA proteins disturbs cellular sorting path-
ways, specifically those involved in TfR but not EGF
receptor turnover.
GGA overexpression alters the localization of cellular 
endosomal sorting factors important for retrovirus budding
We next studied the effect of GGA overexpression on the
localization of host factors described to be important for
retrovirus release. To this end, cells were transfected with
vectors expressing HA-tagged Tsg101 and Myc-tagged
GGA1, 2, or 3 and analyzed by fluorescence microscopy.
Exogenously expressed, full-length Tsg101 (TSG-F) local-
ized to enlarged endosomal structures throughout the cell
(Figure 5A, control panel). Interestingly, however, GGA
overexpression led to sequestration of exogenous Tsg101
on GGA-induced structures with high degree of colocali-
zation (R ~ 0.7). We next studied the effect of GGA over-
expression on Hrs, which recognizes ubiquitinated cargo
on early endosomes as part of a complex with signal trans-
ducing adaptor molecule 1 (STAM1) and STAM2 [14].
HeLa cells were cotransfected with vectors expressing Myc-
tagged Hrs and GFP-tagged GGA proteins (which also
induce vacuolar-like structures) and were analyzed by flu-
orescence microscopy. As expected [58], when expressed
alone, Myc-Hrs localized to small puncta typical of early
endosomes (Figure 5B, control panel). However, a differ-
ent localization pattern was observed upon overexpres-
sion of the GGA proteins. GGA1 overexpression did not
significantly alter the localization pattern of Hrs nor was
there appreciable GGA1/Hrs colocalization. In contrast,
Hrs appeared to localize to the limiting membrane of
GGA2-induced structures and colocalized with GGA3 to a
significant extent (R ~ 0.8) (Figure 5B).
GGA-induced structures sequester ubiquitinated cargo
To further define the composition of the GGA-induced
structures, we next asked whether they sequester ubiquitin
or ubiquitinated cargo. HeLa cells transfected with GGA
expression vectors were stained with an antibody that rec-
ognizes polyubiquitinated proteins but not free ubiquitin
[59]. As shown in Figure 6A, GGA-induced structures were
strongly positive for ubiquitinated cargo, especially in the
case of GGA1 and GGA3. To confirm the previous obser-
vation that GGA proteins bind directly to ubiquitin
[49,60-64], lysates from cells expressing Myc-tagged GGAs
Treatment with BFA dissociates endogenous GGAs from  membranes but does not disrupt the structures induced by  GGA overexpression Figure 2
Treatment with BFA dissociates endogenous GGAs 
from membranes but does not disrupt the structures 
induced by GGA overexpression. HeLa cells were left 
untransfected, or were transfected with 0.5 μg vectors 
expressing WT GGAs or NA mutants defective in Arf bind-
ing (NA). Approximately 24 h posttransfection, cells were 
left untreated (-BFA) or were treated with BFA at 4 μg/ml 
for 1 h (+BFA). Cells were then fixed, stained with anti-GGA 
antibodies for visualization of endogenous GGAs or anti-Myc 
antibody for detection of exogenous GGAs, and analyzed by 
fluorescence microscopy. Size bar represents 15 μm.
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were immunoprecipitated with ubiquitin-agarose beads
followed by immunoblotting with anti-Myc antibody. We
observed that all the GGA proteins bound to ubiquitin-
agarose but not protein A-agarose beads (Figure 6B). The
GGA3 L276A mutant, which displays impaired ubiquitin
binding [49] but still induces the formation of aberrant
compartments (data not shown), served as a negative con-
trol (Figure 6B). Because GGA-induced structures accumu-
late ubiquitinated proteins (Figure 6A) and GGA
overexpression inhibits HIV-1 release [37], we asked
whether expression of exogenous ubiquitin could reverse
GGA-mediated inhibition of HIV release. HeLa cells were
transfected with a ubiquitin expression vector along with
GGA expression constructs and analyzed by microscopy.
Surprisingly, expression of ubiquitin led to disappearance
of the large GGA-induced structures (Figure 6C). GGA
proteins were expressed at comparable levels in the pres-
ence or absence of ubiquitin overexpression, as deter-
mined by Western blot analysis (data not shown). Similar
results were obtained when GGA vector DNA was used in
a five-fold excess relative to ubiquitin expression plasmid
(data not shown). As a control, we examined whether
ubiquitin overexpression disrupted the accumulation of
compartments induced by TSG-3'. As shown in Figure 6C,
ubiquitin overexpression had no effect on the formation
of TSG-3'-induced structures. Finally, we investigated
whether exogenous ubiquitin expression affected the virus
release defect induced by GGA overexpression. Remarka-
bly, we observed that cotransfection of ubiquitin and
GGA expression vectors rescued HIV-1 particle production
when compared to transfection of GGA vectors alone (Fig-
ure 6D). Together, these data indicate that GGA-induced
structures sequester ubiquitinated proteins. Moreover,
expression of exogenous ubiquitin along with the GGA
proteins diminishes the induction of vacuole-like com-
partments, which correlates with partial rescue of virus
release.
Gag sequestration in GGA1-induced structures requires the 
MA domain and Gag binding to membrane
We demonstrated previously that GGA overexpression
inhibits retrovirus particle production, which in the case
GGA-induced compartments colocalize with the aggresome marker GFP-250 Figure 3
GGA-induced compartments colocalize with the aggresome marker GFP-250. (A) HeLa cells were cotransfected 
with vectors expressing Myc-tagged GGAs or HA-tagged TSG-3' and GFP-250 at a 1:1 input DNA ratio. Cells were fixed 
approximately 24 h posttransfection, stained with anti-Myc or anti-HA antibodies, and analyzed by fluorescence microscopy. 
Numbers represent mean colocalization (R value) ± SD from 10 cells. Size bar represents 15 μm. (B) HeLa cells transfected 
with GGA or TSG-3' expression vectors were fixed 24 h posttransfection and analyzed by transmission EM. Size bar repre-
sents 500 nm.
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of GGA1 is in part due to sequestration of HIV-1 Gag in
GGA1-induced structures [37]. We also observed that an
HIV-1 construct lacking the MA domain (Fyn10deltaMA)
is resistant to inhibition mediated by GGA overexpression
[37]. We therefore sought to define the determinants in
HIV-1 Gag responsible for recruitment into GGA1-
induced compartments. HeLa cells were transfected with
the GGA1 expression vector along with either full-length
pNL4-3; Fyn10fullMA, a pNL4-3 derivative expressing
Gag bearing at its N terminus the ten-amino-acid mem-
brane-targeting signal from Fyn [65]; Fyn10deltaMA, a
pNL4-3 derivative expressing Gag bearing the ten amino
acid residues from Fyn and lacking the MA domain [66];
or pNL4-3/1GA, which expresses a non-myristylated Gag
mutant [67]. Cells were then stained using an anti-HIV-1
p24 (CA) antibody and the degree of colocalization
between GGA1 and Gag was quantified. Interestingly,
GGA1-induced structures sequestered WT and
Fyn10fullMA Gag but not Fyn10deltaMA Gag suggesting
a requirement for the MA domain in Gag sequestration
(Figure 7A). Moreover, the GGA1-induced structures did
not colocalize with 1GA Gag, demonstrating that Gag
recruitment into GGA1-induced structures required Gag-
membrane binding (Figure 7A). Finally, we asked whether
non-HIV-1 Gag proteins are also sequestered in GGA1-
induced structures. Interestingly, EIAV Gag showed a high
degree (R > 0.8) of colocalization with GGA1-induced
structures (Figure 7A) whereas MLV Gag demonstrated a
lower level of colocalization (R < 0.4) with these struc-
tures (data not shown).
Discussion
Previously we showed that GGA overexpression modu-
lates retrovirus assembly by inhibiting Gag targeting to the
PM. GGA overexpression also induced the accumulation
of large vacuolar structures, which in the case of GGA1
sequestered HIV-1 Gag [37]. In the current study, we
investigated in detail the morphology and composition of
GGA-induced compartments and the impact of their for-
mation on normal cellular physiology and retrovirus
release. We observed that GGA-induced compartments
stained positively for Golgi and aggresome markers, and
GGA overexpression caused defects in endosomal sorting.
Moreover, GGA overexpression also altered the localiza-
tion of various host proteins important for retrovirus
assembly. Overexpression of ubiquitin led to a dissolu-
tion of the GGA-induced structures and a partial rescue of
HIV-1 release. Study of determinants for HIV-1 Gag
GGA overexpression perturbs cellular sorting pathways Figure 4
GGA overexpression perturbs cellular sorting pathways. (A) HeLa cells were transfected with Myc-tagged GGA 
expression vectors. 24 h posttransfection, cells were washed and incubated for 30 min at 4°C in SFM containing 10 μg/ml Tf-
594 then incubated at 37°C for 15 min. Cells were fixed and stained with anti-Myc antibody for transferrin binding and uptake 
assay. Lower panel: control untransfected cells were incubated with Tf-594 as indicated above and fixed immediately (0 min) or 
after a 15 min chase. (B) HeLa cells transfected with GGA expression constructs were stained with anti-TfR antibody followed 
by fluorescence microscopy. Lower panel, untransfected cell control. (C) HeLa cells were transfected with Myc-tagged GGA 
expression constructs, stained with anti-CD-MPR antibody followed by microscopy. Numbers represent average colocalization 
(R value) ± SD from 10 cells. Size bar represents 15 μm.
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sequestration in GGA1-induced compartments demon-
strated a role for the MA domain. Thus, GGA overexpres-
sion not only inhibits retrovirus assembly and Gag
localization but also alters the cellular sorting pathways
important for normal cellular physiology.
GGA proteins when expressed exogenously in cells
whether transiently or stably have been reported to show
a localization pattern similar to that of their endogenous
counterparts [48,49]. Indeed, tagged GGA expression vec-
tors have been widely used in the field of cell biology to
substitute for the use of GGA antibodies. However, we
observe defects in endosomal sorting induced by even
moderate levels of GGA overexpression and the formation
of vacuolar compartments in which the exogenously
expressed GGA proteins are localized. This phenotype is
similar to the GGA expression pattern reported previ-
ously, namely, "compaction and fizzling" of Golgi stacks
and accumulation of fragmented vacuolar-like blobs that
contain Golgi markers [52,68,69]. GGA overexpression
also led to striking changes in TfR distribution and recy-
cling of CD-MPR. Following ligand binding to the TfR,
both receptor and ligand are rapidly internalized and
transported to acidic compartments in which the receptor
is released and recycled back to the cell surface [70,71].
However, in cells overexpressing the GGA proteins, there
was no evidence of the bright cell surface staining with flu-
orescently tagged transferrin that is observed in cells not
overexpressing the GGAs. This loss in transferrin binding
was due to sequestration of TfR in GGA-induced compart-
ments. GGA overexpression led to the accumulation of
CD-MPR in the Golgi with a concomitant depletion from
the periphery. This alteration in CD-MPR recycling has
also been described previously in cells expressing a domi-
nant-negative fragment of GGA1 comprising the VHS-
GAT domain but lacking the hinge and GAE domains
[72].
GGA overexpression also led to alterations in the subcel-
lular localization of several host proteins implicated in
retrovirus assembly and release. We previously observed
that GGA overexpression led to sequestration of Arfs [37].
Moreover, GGA overexpression also caused a shift in the
localization of overexpressed Tsg101 and Hrs (Figure 5).
GGA overexpression alters the localization of endosomal sorting factors Figure 5
GGA overexpression alters the localization of endosomal sorting factors. HeLa cells were transfected with vectors 
expressing (A) Myc-tagged GGAs and HA-tagged TSG-F or (B) GFP-tagged GGAs and Myc-tagged Hrs. Cells were fixed 
approximately 24 h posttransfection, stained with anti-HA and anti-Myc antibodies (A) or anti-Myc antibody (B) followed by 
microscopy. Numbers represent mean colocalization (R value) ± SD from 8-10 cells. Size bar represents 15 μm.
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Of particular interest were the observations that GGA-
induced compartments sequestered ubiquitinated cargo
and providing exogenous ubiquitin not only resolved the
GGA-induced structures but also rescued HIV-1 release
(Figure 6). We speculate that GGA-induced structures are
formed as a result of misfolded protein accumulation,
which due to ubiquitin sequestration are incapable of
being targeted for proteasomal degradation [73,74]. Pro-
viding exogenous ubiquitin could facilitate destruction of
misfolded proteins leading to the disappearance of GGA-
induced structures. Interestingly, this phenomenon was
not observed for TSG-3'-induced structures despite their
ability to sequester ubiquitinated cargo. The observations
that BFA did not disrupt the GGA-induced compartments
and that these compartments were still induced by the Arf-
binding-deficient GGA mutants (Figure 2) argue that for-
mation of the GGA-induced structures is independent of
Arf binding and GGA membrane association. These GGA-
induced structures possess some properties of aggresomes
[for example, they stain with the aggresome marker GFP-
250 (Figure 3)] but are clearly distinct in terms of compo-
sition and inhibitory activity from the aggresome-like
GGA-induced structures sequester ubiquitinated proteins Figure 6
GGA-induced structures sequester ubiquitinated proteins. (A) HeLa cells were transfected with Myc-tagged GGA 
expression vectors, fixed, and stained using antibodies specific for the Myc epitope tag or for polyubiquitinated proteins. Num-
bers represent average colocalization (R values) ± SD from 10 cells. (B) GGAs bind directly to ubiquitin. HeLa cells were 
transfected with vectors expressing the indicated Myc-GGAs. Cell lysates were immunoprecipitated with ubiquitin-agarose or 
protein A (PrA) agarose beads followed by Western blotting using anti-Myc antibody. (C) HeLa cells were transfected with 
GGA or TSG-3' expression constructs alone or were cotransfected with the ubiquitin expression vector pCW7. Cells were 
fixed, stained, and analyzed for immunofluorescence. (D) HeLa cells were transfected with pNL4-3 along with control or 
GGA1, GGA2 or GGA3 expression vectors in the presence or absence of control DNA or ubiquitin expression vector. Trans-
fected cells were labeled with [35S]Met/Cys, cell and virus lysates immunoprecipitated with HIV-Ig followed by resolution on an 
SDS-PAGE gel. Error bars indicate mean ± SD, n = 3. Size bar represents 15 μm.
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structures induced by TSG-3'. Most notably, TSG-3'-
induced structures primarily block virus budding and do
not interfere with EIAV release [42,43], whereas GGA-
induced structures impair Gag association with mem-
brane and display inhibitory activity against HIV-1 and
EIAV ([37]; this study). The distinct phenotypes of these
compartments is likely due to differences in the proteins
that they sequester. Purification of these aberrant struc-
tures and proteomic characterization of their composition
would potentially provide additional insights into host
cell machinery required for Gag trafficking to the plasma
membrane and virus budding.
Although the three mammalian GGA proteins are closely
related, in our studies they have shown some notable dif-
ferences: 1) depletion of GGA3, and to a lesser extent
GGA2, stimulated HIV-1 release whereas GGA1 depletion
did not [37]. 2) Whereas the compartments induced by
overexpression of each of the three GGA proteins stained
positively for the TGN marker TGN46, only those induced
by GGA3 were positive for the detergent-insoluble cis-
Golgi marker GM130 (Figure 1). 3) Compartments
induced by GGA1 trapped HIV-1 Gag, whereas those
induced by GGA2 or GGA3 did not [37]. It remains to be
determined whether the GGA proteins interact directly
with Gag or whether differential association with other
host cell factors could explain the ability of GGA1 but not
GGA2 or GGA3 overexpression to trap Gag. In this study,
we observed that Fyn10deltaMA and the non-myristylated
HIV-1 Gag mutant were not sequestered in GGA1-induced
compartments, indicating a requirement for the MA
domain and Gag membrane binding in Gag trapping.
In contrast to the Gag sequestration data, in virus release
assays both Fyn10FullMA (Joshi and Freed, unpublished)
and Fyn10deltaMA [37] were resistant to inhibition medi-
ated by GGA overexpression. This observation suggests
that Gag sequestration is not the sole cause of inhibition
mediated by GGA1 overexpression. It is also possible that
the Fyn targeting signal, which confers strong membrane
binding ability, is able to rescue the inhibition. Interest-
ingly, EIAV particle production is also inhibited by GGA
overexpression [37] and EIAV Gag is sequestered in
GGA1-induced structures (Figure 7B). Moreover, while
overexpression of GGA2 and GGA3 mutants defective in
Arf binding (the GGA-NA mutants) was no longer inhibi-
tory to HIV-1 and EIAV release, the GGA1-NA mutant was
still capable of inhibition and Gag sequestration [37].
Overall, these findings indicate intriguing differences in
the mechanisms by which overexpression of the three
GGA proteins inhibit retroviral particle production.
Conclusion
In the current study, we extend our previous findings and
characterize in detail the structures induced by GGA over-
expression with respect to their impact on cellular sorting
pathways and their ability to inhibit retroviral particle
production. We observe that the compartments induced
by GGA overexpression are distinct from those formed by
dominant-negative components of the ESCRT pathway,
both in terms of their effect on cellular functions and with
respect to the step in the retrovirus assembly and release
pathway that they disrupt. A better understanding of these
host components will not only further our knowledge of
cellular sorting processes but also help define the require-
ments for host factors in retrovirus assembly and release.
Methods
Cell culture and transfections
HeLa cells were cultured in DMEM supplemented with
5% fetal bovine serum (FBS) and 2 mM glutamine. All
Sequestration of retroviral Gag proteins in GGA1-induced  structures Figure 7
Sequestration of retroviral Gag proteins in GGA1-
induced structures. (A) HeLa cells were transfected with 
the Myc-tagged GGA1 expression vector along with WT 
pNL4-3, or the Fyn10fullMA, Fyn10deltaMA, or 1GA deriva-
tives. Cells were fixed approximately 24 h posttransfection, 
stained using anti-Myc and anti-HIV-1 p24 antibodies fol-
lowed by immunofluorescence analysis. Numbers represent 
average colocalization (R value) ± SD from 10 cells. Size bar 
represents 15 μm. (B) HeLa cells were cotransfected with 
vectors expressing Myc-tagged GGA1 and EIAV Gag. Cells 
were fixed, stained using anti-Myc and anti-EIAV p26 antibod-
ies and analyzed as indicated above. Numbers represent 
mean colocalization (R value) ± SD from 7-10 cells.
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transfections were performed using Lipofactamine2000™
reagent (Invitrogen) as per the manufacturer's instruc-
tions.
Reagents
Plasmids expressing full-length Myc-tagged GGA proteins
were kindly provided by J. Bonifacino (NIH, Bethesda
MD) [39,48,49]. The GGA3 mutant defective in ubiquitin
binding (L276A) [49] was constructed by site-directed
mutagenesis. The full-length HIV-1 proviral clone pNL4-3
[75] and the myristylation-deficient mutant pNL4-3/1GA
[67] have been previously reported. The ubiquitin expres-
sion vector pCW7 [76] was provided by R. Kopito (Stan-
ford University, CA). An HIV-1 derivative bearing at its N
terminus ten amino acids from the membrane targeting
sequence of Fyn (Fyn10fullMA) [65] and its derivative
lacking the MA domain (Fyn10deltaMA) [66] have been
described. HA-tagged Tsg101 expression constructs TSG-F
and TSG-3' have been reported [42,77]. The Hrs expres-
sion vector was constructed by amplifying the Hrs coding
region from a cDNA library by PCR and inserting the
amplified fragment between the BamHI and XbaI sites of
pcDNA3.1. The EIAV Gag expression vector pPRE/Gag has
been reported previously [43,78]. The aggresome marker
GFP-250 [57] was kindly provided by E. S. Sztul (Univer-
sity of Alabama at Birmingham, Birmingham AL). The
pEGFPhVPS4A (E228Q) expressing an ATPase-deficient
mutant of VPS4A fused to GFP was a gift from P. Wood-
man (University of Manchester, UK) [50]. The anti-GGA1
antibody was a kind gift from R. Kahn (Emory University,
Atlanta, GA) [52]; anti-GGA2 and GGA3 antibodies were
purchased from BD Biosciences. The mouse anti-GM130
antibody was from Transduction Laboratories (Lexington,
KY) and sheep anti-TGN46 was from Serotec (Oxford,
United Kingdom). EIAV anti-p26 antibody was kindly
provided by R. Montelaro (University of Pittsburg). EGF-
Texas Red and Transferrin Alexa Fluor 594 (Tf-594) conju-
gates were from Molecular Probes (Invitrogen). The anti-
polyubiquitin antibody was from Biomol (clone Fk1).
The anti-CD-MPR antibody (clone 22d4) was obtained
from University of Iowa Developmental Studies Hybrid-
oma bank and anti-TfR antibody was from Zymed. BFA
was purchased from Calbiochem. Protein A beads were
from Invitrogen and ubiquitin-agarose beads were
obtained from Sigma.
Immunofluorescence and EM analysis
Immunostaining of cells was performed as described [79],
with minor modifications. Cells seeded onto Nunc Lab-
Tek II chamber slides were rinsed with phosphate-buff-
ered saline (PBS) and fixed with 3.7% formaldehyde in
100 mM sodium phosphate buffer (pH 7.2) for 20 min.
Following fixation, cells were thoroughly rinsed with PBS,
permeabilized using 0.1% Triton X-100/PBS for 2 min,
and incubated for 10 min with 0.1 M glycine/PBS to
quench the remaining aldehyde residues. Cells were then
blocked with 3% BSA/PBS for 30 min, followed by incu-
bation for 1 h with primary antibody appropriately
diluted in 3% BSA/PBS. After 3 washes in PBS, cells were
incubated for 30 min with secondary antibody diluted in
3% BSA/PBS. Cells were then washed and mounted using
Aqua Poly/Mount (Polysciences Inc). Images were
acquired with a DeltaVision RT microscope. To quantify
colocalization, we calculated the Pearson correlation coef-
ficient (R) values, which are standard measures of colocal-
ization [80]. The R values were calculated using the
softWoRx colocalization module which generates a "colo-
calized" image from two channels. A scatter plot of the
two intensities on a pixel-by-pixel basis was plotted and
the R value calculated by dividing the covariances of each
channel by the product of their standard deviations. For
EM analysis, transfected cells were fixed using buffer con-
taining 2% glutaraldehyde and 100 mM sodium
cacodylate and stored at 4°C. Samples were then sec-
tioned and analyzed by transmission EM [67].
EGF and TfR internalization assays
24 h posttransfection, cells were washed three times with
serum free medium (SFM) containing 20 mM HEPES and
1% BSA and incubated for 1 h at 37°C in the same
medium. Cells were then placed on ice for 5 min followed
by incubation for 30 min at 4°C in SFM containing 5 μg/
ml EGF-Texas Red or 10 μg/ml Tf-594 (Molecular Probes).
Cells were washed three times with PBS and incubated in
cell culture medium at 37°C for 15 min for TfR and 30
min for EGF receptor. Finally, cells were washed with PBS,
fixed and mounted using DAPI-containing medium for
EGF receptor assays.
Metabolic labeling and immunoprecipitation
The protocol for radiolabeling and immunoprecipitation
of cell and virus lysates has been described in detail previ-
ously [67]. Briefly, transfected cells were starved for 30
min in labeling media lacking Met and Cys. Thereafter,
cells were incubated for 2-3 h in labeling medium supple-
mented with FBS and [35S]Met/Cys. Culture supernatants
were ultracentrifuged at 100,000 × g for 45 min, cell and
virus lysates were immunoprecipated with HIV-Ig,
resolved by SDS-PAGE followed by PhosphorImager anal-
ysis. Virus release was calculated as the percentage of vir-
ion-associated p24 (CA) relative to total (virion + cell-
associated) Gag. Virus release efficiency = virion p24/(cell
associated Pr55Gag + cell-associated p24+virion-associated
p24) × 100.
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infectious anemia virus; EM: electron microscopy; ER:
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plex required for transport; FBS: fetal bovine serum; FIV:
feline immunodeficiency virus; GAE: γ-adaptin ear
homology domain; GAT: GGA and Tom domain; GGA:
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nositol-(4,5)-bisphosphate; PM: plasma membrane;
POSH: plenty of SH-3s; PR: protease; P(T/S)AP: Pro-Thr/
Ser-Ala-Pro; RSV: Rous sarcoma virus; SDS-PAGE: sodium
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